Home / Brands / GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline Recalls
10 recalls on record · April 30, 2014 to April 30, 2014 · Drugs
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC On
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicorette (nicotine polacrilex) Lozenges Mini, 2 mg, Original Flavor, 20 Lozenge, 27 Lozenge, 81 Lozenge and 135 Lozenge
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicorette Lozenge, Nicoderm CQ, and Nicorette Gum nicotine polacrilex combination. Contains 30 Pieces/ Pallet. OTC on
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicotine polacrilex lozenge, 4 mg, Mint Flavor, 81 Lozenge and 189 Lozenge Vials. OTC. Labeled Nicorette, Distributed By
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicotine polacrilex lozenge, 2 mg, Mint Flavor, 81 count cartons and 189 count cartons. OTC. Labeled Nicorette, Distribu
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labe
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicotine polacrilex lozenge, 4 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labe
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicotine polacrilex lozenge, 4 mg, Cherry Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labele
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
April 30, 2014DrugsFDA
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalls Nicotine polacrilex lozenge, 2 mg, Cherry Flavor, 72 count vials, 81 count vials, and 108 count vials. OTC. Labeled a. N
Hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.